Neuronetics Inc
For the period ended Dec 31, 2023. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 8, 2024
STIM$2.18+1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations
(In thousands, except per share data)
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · Years ended December 31, | |||||||||
| · · 2023 · · 2022 · · 2021 | |||||||||
| Revenues | | $71,348 | $65,206 | $55,312 | |||||
| Cost of revenues | | 19,643 | | 15,483 | | 11,653 | |||
| Gross profit | | 51,705 | | 49,723 | | 43,659 | |||
| Operating expenses: | | | | | |||||
| Sales and marketing | | 47,318 | | 49,982 | | 37,746 | |||
| General and administrative | | 25,426 | | 25,516 | | 25,554 | |||
| Research and development | | 9,515 | | 9,336 | | 7,923 | |||
| Total operating expenses | | 82,259 | | | 84,834 | | 71,223 | ||
| Loss from operations | | (30,554) | | (35,111) | | (27,564) | |||
| Other (income) expense: | | | | | |||||
| Interest expense | | 5,424 | | 4,251 | | 4,019 | |||
| Other income, net | | (5,789) | | (2,203) | | (390) | |||
| Net loss | | $(30,189) | | $(37,159) | | $(31,193) | |||
| Net loss per share of common stock outstanding, basic and diluted | | $(1.05) | | $(1.38) | | $(1.22) | |||
| Weighted-average common shares outstanding, basic and diluted | | 28,658 | | 26,900 | | 25,479 | |||
| | | | | | | | | | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.